Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008

Introduction: International guidelines and new targeted therapies for idiopathic pulmonary fibrosis have increased the need for accurate diagnosis of interstitial lung disease, which may lead to more surgical lung biopsies. This study aims to assess the risk of this procedure in patients from the Un...

Full description

Bibliographic Details
Main Authors: Hutchinson, John P., McKeever, Tricia M., Fogarty, Andrew W., Navaratnam, Vidya, Hubbard, Richard B.
Format: Article
Published: European Respiratory Society 2016
Subjects:
Online Access:https://eprints.nottingham.ac.uk/34719/
_version_ 1848794919941963776
author Hutchinson, John P.
McKeever, Tricia M.
Fogarty, Andrew W.
Navaratnam, Vidya
Hubbard, Richard B.
author_facet Hutchinson, John P.
McKeever, Tricia M.
Fogarty, Andrew W.
Navaratnam, Vidya
Hubbard, Richard B.
author_sort Hutchinson, John P.
building Nottingham Research Data Repository
collection Online Access
description Introduction: International guidelines and new targeted therapies for idiopathic pulmonary fibrosis have increased the need for accurate diagnosis of interstitial lung disease, which may lead to more surgical lung biopsies. This study aims to assess the risk of this procedure in patients from the United Kingdom. Methods: We used Hospital Episodes Statistics data from 1997-2008 to assess the frequency of surgical lung biopsy for interstitial lung disease in England. We identified cardiothoracic surgical patients using ICD-10 codes for interstitial lung disease and OPCS-4 codes for surgical lung biopsy. We excluded those with lung resections or lung cancer. We estimated in-hospital, 30-day and 90-day mortality following the procedure, and linked to cause of death using data from the Office of National Statistics. Results: We identified 2,820 patients with interstitial lung disease undergoing surgical lung biopsy during the 12 year period. The number of biopsies increased over the time period studied. In-hospital, 30-day and 90-day mortality were 1.7%, 2.4% and 3.9% respectively. Male sex, increasing age, increasing co-morbidity and open surgery were risk factors for mortality. Discussion: Surgical lung biopsy for interstitial lung disease has a similar mortality to lobectomy for lung cancer, and clinicians and patients should understand the likely risks involved.
first_indexed 2025-11-14T19:23:51Z
format Article
id nottingham-34719
institution University of Nottingham Malaysia Campus
institution_category Local University
last_indexed 2025-11-14T19:23:51Z
publishDate 2016
publisher European Respiratory Society
recordtype eprints
repository_type Digital Repository
spelling nottingham-347192020-05-04T18:10:03Z https://eprints.nottingham.ac.uk/34719/ Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008 Hutchinson, John P. McKeever, Tricia M. Fogarty, Andrew W. Navaratnam, Vidya Hubbard, Richard B. Introduction: International guidelines and new targeted therapies for idiopathic pulmonary fibrosis have increased the need for accurate diagnosis of interstitial lung disease, which may lead to more surgical lung biopsies. This study aims to assess the risk of this procedure in patients from the United Kingdom. Methods: We used Hospital Episodes Statistics data from 1997-2008 to assess the frequency of surgical lung biopsy for interstitial lung disease in England. We identified cardiothoracic surgical patients using ICD-10 codes for interstitial lung disease and OPCS-4 codes for surgical lung biopsy. We excluded those with lung resections or lung cancer. We estimated in-hospital, 30-day and 90-day mortality following the procedure, and linked to cause of death using data from the Office of National Statistics. Results: We identified 2,820 patients with interstitial lung disease undergoing surgical lung biopsy during the 12 year period. The number of biopsies increased over the time period studied. In-hospital, 30-day and 90-day mortality were 1.7%, 2.4% and 3.9% respectively. Male sex, increasing age, increasing co-morbidity and open surgery were risk factors for mortality. Discussion: Surgical lung biopsy for interstitial lung disease has a similar mortality to lobectomy for lung cancer, and clinicians and patients should understand the likely risks involved. European Respiratory Society 2016-09-22 Article PeerReviewed Hutchinson, John P., McKeever, Tricia M., Fogarty, Andrew W., Navaratnam, Vidya and Hubbard, Richard B. (2016) Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008. European Respiratory Journal, 48 . pp. 1453-1461. ISSN 1399-3003 Idiopathic Pulmonary Fibrosis Interstitial Lung Disease Surgical Lung Biopsy Mortality http://erj.ersjournals.com/content/early/2016/09/22/13993003.00378-2016 doi:10.1183/13993003.00378-2016 doi:10.1183/13993003.00378-2016
spellingShingle Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease
Surgical Lung Biopsy
Mortality
Hutchinson, John P.
McKeever, Tricia M.
Fogarty, Andrew W.
Navaratnam, Vidya
Hubbard, Richard B.
Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008
title Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008
title_full Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008
title_fullStr Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008
title_full_unstemmed Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008
title_short Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008
title_sort surgical lung biopsy for the diagnosis of interstitial lung disease in england: 1997-2008
topic Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease
Surgical Lung Biopsy
Mortality
url https://eprints.nottingham.ac.uk/34719/
https://eprints.nottingham.ac.uk/34719/
https://eprints.nottingham.ac.uk/34719/